Comparison Chart Opus Genetics, Inc.

IRD

US67577R1023

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	OPUS GENETICS, INC.	Other Pharmaceuticals	+5.57%	-12.47%	+74.63%	+75.50%	-12.03%	276M

Real-time Estimate Cboe BZX 22:28:13 27/10/2026 +03			5-day change	1st Jan Change
3.450 ^USD	+3.92%		-12.47%	+74.63%

10-21	Opus Genetics, Inc. Announces Transition of Ashwath Jayagopal from Chief Scientific and Development Officer, Effective October 19, 2026	CI
10-21	Opus Genetics Wins FDA Clearance for Childhood Blindness Gene Therapy	MT

Comparison Chart Opus Genetics, Inc.

Stocks

IRD

US67577R1023

Pharmaceuticals

Compared values